4.6 Article

The way to cover prediction for cytotoxicity for all existing nano-sized metal oxides by using neural network method

Journal

NANOTOXICOLOGY
Volume 11, Issue 4, Pages 475-483

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/17435390.2017.1310949

Keywords

Neural network; QSAR; metal oxides nanoparticles; cytotoxicity; Periodic table

Funding

  1. Javna Agencija za Raziskovalno Dejavnost RS [P1-0017, BI-US/16-17-014]
  2. Ministerstwo Nauki i Szkolnictwa Wyzszego [DS 530-8637-D510-16]
  3. National science foundation [IIA-1355466]
  4. Office Of The Director
  5. Office of Integrative Activities [1355466] Funding Source: National Science Foundation

Ask authors/readers for more resources

The regulatory agencies should fulfil the data gap in toxicity for new chemicals including nano-sized compounds, like metal oxides nanoparticles (MeOx NPs) according to the registration, evaluation, authorisation and restriction of chemicals (REACH) legislation policy. This study demonstrates the perspective capability of neural network models for prediction of cytotoxicity of MeOx NPs to bacteria Escherichia coli (E. coli) for the widest range of metal oxides extracted from Periodic table. The counter propagation artificial neural network (CP ANN) models for prediction of cytotoxicity of MeOx NPs for data sets of 17, 36 and 72 metal oxides were employed in the study. The cytotoxicity of studied metal oxide NPs was correlated with (i) chi-metal electronegativity (EN) by Pauling scale and composition of metal oxides characterised by (ii) number of metal atoms in oxide, (iii) number of oxygen atoms in oxide and (iv) charge of metal cation in oxide. The paper describes the models in context of five OECD principles of validation models accepted for regulatory use. The recommendations were done for the minimal number of cytotoxicity tests needs for evaluation of the large set of MeOx with different oxidation states. The methodology is expected to be useful for potential hazard assessment of MeOx NPs and prioritisation for further testing and risk assessment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available